Organon & Co. (OGN)
9.405
-0.36
(-3.64%)
USD |
NYSE |
Apr 20, 12:03
Organon Shareholders Equity (Quarterly) : 752.00M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| Abbott Laboratories | -- |
| Gilead Sciences, Inc. | 22.70B |
| Pfizer Inc. | 86.48B |
| Replimune Group, Inc. | 210.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.87B |
| Total Liabilities (Quarterly) | 12.12B |
| Debt to Equity Ratio | 11.70 |
| Current Ratio | 1.821 |
| Net Debt Paydown Yield | -0.55% |